S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% BITCOIN 64,448.05 -0.54%
Next Bullish Trade
Sign in
ZBH

Zimmer Biomet Holdings, Inc. ZBH

$91.12 -2.63 (-2.81%)
Neutral · +0.44σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · ZBH

Momentum reads · latest daily bar
Last
$91.12
-2.63 (-2.81%)
Mkt cap
$17.6B
Healthcare
RSI(14)
53.5
neutral
Stochastic %K
67.6
neutral
MFI(14)
51.8
neutral
ADX(14)
14.3
weak trend

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $2.1B $0.2B $0.4B $0.3B 11.4% 18.9%
2025-12-31 $2.2B $0.1B $0.3B $0.4B 6.2% 12.6%
2025-09-30 $2.0B $0.2B $0.3B $0.4B 11.5% 16.9%
2025-06-30 $2.1B $0.2B $0.4B $0.3B 7.4% 19.1%
2025-03-31 $1.9B $0.2B $0.3B $0.3B 9.5% 17.8%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare ZBH vs peers

Line ZBH up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing ZBH no peers yet — add up to 4 below

Add tickers to compare with ZBH

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-04-28 2.09 1.86 +12.2% -3.3%
2026-02-10 2.42 2.40 +0.9% +4.6%
2025-11-05 1.90 1.87 +1.8% +1.1%
2025-08-07 2.07 1.98 +4.8% +0.8%
2025-05-05 1.81 1.77 +2.3% +2.0%
2025-02-06 2.31 2.29 +0.8% -1.7%
2024-10-30 1.74 1.74 +0.2% -2.6%
2024-08-07 2.01 1.99 +0.9% +2.7%
2024-05-02 1.94 1.87 +3.8% +2.7%
2024-02-08 2.20 2.16 +2.0% -0.2%
2023-11-07 1.65 1.60 +2.9% -1.0%
2023-08-01 1.82 1.81 +0.4% -2.9%
2023-05-02 1.89 1.64 +15.2% -2.4%
2023-02-03 1.88 1.83 +2.8% -0.7%
2022-11-02 1.58 1.56 +1.6% -2.1%
2022-08-02 1.82 1.64 +10.7% +1.4%
2022-05-03 1.61 1.42 +13.8% +4.7%
2022-02-07 1.95 1.98 -1.3% +7.3%
2021-11-04 1.81 1.76 +3.1% +2.8%
2021-08-03 1.90 1.86 +1.9% -3.6%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
ZBH $18B 23.6 10.1 2.1 9.6 1.4 70.2% 9.3% 34.1% 5.92%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 56.89%

HolderShares% out
Dodge & Cox Inc. 23,542,700 12.17%
Blackrock Inc. 15,340,806 7.93%
Harris Associates L.P. 12,959,939 6.70%
Vanguard Capital Management LLC 12,793,412 6.61%
Capital International Investors 9,119,222 4.71%
State Street Corporation 8,825,127 4.56%
Vanguard Portfolio Management LLC 8,650,228 4.47%
Price (T.Rowe) Associates Inc 7,999,712 4.14%
Franklin Resources, Inc. 5,452,665 2.82%
Geode Capital Management, LLC 5,379,525 2.78%

Insider activity · 90d

13 buys / 2 sells · ratio 6.5 · Finnhub

  • Shapiro Louis BUY 3,703
  • Kurdikar Devdatt BUY 2,990
  • Kolli Sreelakshmi BUY 6,843
  • Hilado Maria Teresa BUY 12,984
  • Farrell Michael J. BUY 19,607
  • HAGEMANN ROBERT BUY 33,269
  • HIGGINS ARTHUR J BUY 37,675
  • Noor Jehanzeb BUY 1,857
  • Yi Sang SELL 27,251 @ $82.66
  • Yi Sang SELL 28,051 @ $82.64

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$83.0
Mean
$98.6
High
$130.0
Analysts
20
Recommendation distribution · period 2026-07-01
4
8
20
2
Revision trend (2026-04-01 → 2026-07-01): net 8 → 10 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-07-02 Insider transaction (Form 4) view ·
4 2026-07-02 Insider transaction (Form 4) view ·
8-K 2026-06-29 8-K view ·
4 2026-06-03 Insider transaction (Form 4) view ·
4 2026-06-02 Insider transaction (Form 4) view ·
8-K 2026-05-27 8-K view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
4 2026-05-27 Insider transaction (Form 4) view ·
8-K 2026-05-12 8-K view ·
4 2026-05-05 Insider transaction (Form 4) view ·
10-Q 2026-05-01 10-Q view ·
8-K 2026-04-28 8-K view ·
8-K 2026-04-28 8-K view ·
4 2026-04-03 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
4 2026-04-02 Insider transaction (Form 4) view ·
DEF 14A 2026-04-01 DEF 14A view ·
4 2026-03-16 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-03-10 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-27 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-24 Insider transaction (Form 4) view ·
4 2026-02-23 Insider transaction (Form 4) view ·

About ZBH

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specia…

Options picks · ZBH

ITM + OTM ideas from the latest scan

Loading…

Congress trades · ZBH

STOCK Act disclosures

Loading…

SEC filings & insiders · ZBH

EDGAR · live

Loading…

Holders · ZBH

Institutions & insider activity

Loading…